December 9, 2019 —  DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration with IBM Watson Health, a leading provider of innovative AI, enterprise imaging, and interoperability solutions used by medical professionals worldwide.

November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers.

Atrial Fibrillation Symposium (AF Symposium)


The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to becoming the standard of care in just a decade had generated excitement and hopes for similar success with transcatheter treatments for mitral regurgitation.



November 26, 2019 — Physicians from the University of New Mexico (UNM) and local emergency responders recently treated a cardiac arrest patient with the first ever out-of-hospital portable life-support system available in the United States.


November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a technical iteration of MitraClip, was found to be safe and effective for edge-to-edge transcatheter repair of tricuspid regurgitation (TR).

November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have selected the Medable Inc. cloud-based clinical trial platform to evaluate statin-related adverse events. It will use electronic patient-reported outcomes in a digital trial.

The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon (DCB) for the treatment of failing arteriovenous (AV) access in patients with end-stage renal disease (ESRD) undergoing dialysis.

November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to pinpoint patients at higher risk of developing a potentially dangerous irregular heartbeat (arrhythmia) or of dying within the next year, according to two preliminary studies to presented at the American Heart Association’s Scientific Sessions 2019 — November 16-18 in Philadelphia. 

Dorothy and Lloyd Huck Chair of Cardiovascular Medicine
Morristown Medical Center/Atlantic Health System 
Professor of medicine, Sidney Kimmel Medical College, Thomas Jefferson University

 

Subscribe Now